DRI-LYTE
510(k) K780353
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK780353 | Date5 Apr 1978 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KPO
- Device Class
- Class II
- Regulation
- 21 CFR Part 876.5820
- Advisory Committee
- Gastroenterology, Urology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
DRI-LYTE is a dialysate concentrate for hemodialysis, available in liquid or powder form. It is used in the preparation of dialysate solution for hemodialysis treatment.
The device is supplied as a concentrate for reconstitution and use in hemodialysis settings. It is classified as a Class II medical device under FDA regulation 876.5820, with product code KPO, and received traditional 510(k) clearance (K780353) on April 5, 1978, based on substantial equivalence.
Other devices from Mallinckrodt Critical Care
Questions
AI-generated answers, 21 Sep 2026
What is DRI-LYTE used for?
DRI-LYTE is a dialysate concentrate used in the preparation of dialysate solution for hemodialysis treatment. It is reconstituted from liquid or powder form to create the solution that removes waste and excess fluid from blood during dialysis.
How is DRI-LYTE supplied and prepared for use?
DRI-LYTE is supplied as a concentrate in either liquid or powder form, requiring reconstitution with water to prepare the final dialysate solution used in hemodialysis machines. This allows for flexible storage and on-site mixing based on clinical needs.
Is DRI-LYTE intended for single-use or multiple uses?
DRI-LYTE is a concentrate intended for multiple uses after reconstitution; once mixed into dialysate solution, it is used in a single hemodialysis treatment session and then discarded, as the prepared dialysate is not reused.
What regulatory pathway was used for DRI-LYTE's market authorization?
DRI-LYTE received traditional 510(k) clearance from the FDA on April 5, 1978 (K780353), based on demonstration of substantial equivalence to a legally marketed predicate device under regulation 876.5820.